Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
The Prostate
|
January 1, 1997
Monoclonal antibody 7E11.C5 staining of viable LNCaP cells
R J Barren, E H Holmes, A L Boynton, et al.
The Prostate
|
March 1, 1995
Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement
G P Murphy, E H Holmes, A L Boynton, et al.
The Prostate
|
October 1, 1994
Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients
Y P Rochon, J S Horoszewicz, A L Boynton, et al.
The Prostate
|
August 4, 1998
Method for identifying prostate cells in semen using flow cytometry
R J Barren, E H Holmes, A L Boynton, et al.
The Prostate
|
October 8, 1997
Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer
G P Murphy, M J Troychak, O E Cobb, et al.
The Prostate
|
April 1, 1996
Measurement of prostate-specific membrane antigen in the serum with a new antibody
G P Murphy, W T Tino, E H Holmes, et al.
The Prostate
|
December 16, 1997
Comparison of serum PSMA, PSA levels with results of Cytogen-356 ProstaScint scanning in prostatic cancer patients
G P Murphy, R T Maguire, B Rogers, et al.
Cancer
|
August 15, 1996
Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigen
G P Murphy, R J Barren, S J Erickson, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
The Prostate
|
January 1, 1997
Monoclonal antibody 7E11.C5 staining of viable LNCaP cells
R J Barren, E H Holmes, A L Boynton, et al.
The Prostate
|
March 1, 1995
Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement
G P Murphy, E H Holmes, A L Boynton, et al.
The Prostate
|
October 1, 1994
Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients
Y P Rochon, J S Horoszewicz, A L Boynton, et al.
The Prostate
|
August 4, 1998
Method for identifying prostate cells in semen using flow cytometry
R J Barren, E H Holmes, A L Boynton, et al.
The Prostate
|
October 8, 1997
Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer
G P Murphy, M J Troychak, O E Cobb, et al.
The Prostate
|
April 1, 1996
Measurement of prostate-specific membrane antigen in the serum with a new antibody
G P Murphy, W T Tino, E H Holmes, et al.
The Prostate
|
December 16, 1997
Comparison of serum PSMA, PSA levels with results of Cytogen-356 ProstaScint scanning in prostatic cancer patients
G P Murphy, R T Maguire, B Rogers, et al.
Cancer
|
August 15, 1996
Evaluation and comparison of two new prostate carcinoma markers. Free-prostate specific antigen and prostate specific membrane antigen
G P Murphy, R J Barren, S J Erickson, et al.
Page
of 1